Brivaracetam Tablet
Product Images NDC 60505-4723

This text provides information about a medication called Brivaracetam in the form of film-coated tablets containing 100 mg. It includes storage instructions, dosage guidance, and details for pharmacists on dispensing the medication. The tablets are contained in a package with 60 tablets. The manufacturer is Apotex Inc. based in Toronto, Ontario, Canada. The medication guide is enclosed for each patient, and the product is dispensed by Apotex Corp. in Weston, Florida.*

The text contains information about Brivaracetam tablets, including a dosage of 10mg and the manufacturer as Roy APOTEX CORP. It also mentions a controlled room temperature for storage. The text provides valuable details for understanding the medication and its recommended usage.*

This is information related to a medication called Brivaracetam, where each film-coated tablet contains 25 mg of the active ingredient. The tablets should be stored between 20°C to 25°C (68°F to 77°F) with excursions permitted from 15°C to 30°C (59°F to 86°F). The product should be dispensed in a tight container. The usual dosage instructions are mentioned in the accompanying prescribing information. The packaging includes 60 tablets with a specific National Drug Code (NDC) number. The medication guide should be provided to each patient by the pharmacist. The manufacturer is Apotex Inc. located in Toronto, Ontario, Canada. It is manufactured for Apotex Corp. in Weston, Florida.*

This is a description of a medication containing 50 mg of brivaracetam in film-coated tablets. The tablets should be stored between 20°C to 25°C (68°F to 77°F) with excursions allowed between 15°C to 30°C (59°F to 86°F). It is recommended to dispense in a tight container and to provide the enclosed Medication Guide to each patient. The medication is usually taken as directed in the accompanying prescribing information. The manufacturer is Apotex Inc. and distributed by Apotex Corp.*

This text provides information about a medication in tablet form containing 75 mg of brivaracetam. It includes storage conditions, dosage instructions, and details on dispensing. The medication guide is to be dispensed to each patient by the pharmacist. The tablets are manufactured by Apotex Inc. in Toronto, Ontario, Canada, and dispensed by Apotex Corp. in Weston, Florida.*

This is a summary of the proportion of patients in different categories based on seizure reduction when treated with different dosages of Brivaracetam compared to Placebo. The percentages of patients in each category are shown in the table, along with the reduction in seizure frequency from baseline for the different treatment groups. The dosages of Brivaracetam include 50 mg/day, 100 mg/day, and 200 mg/day, with varying sample sizes for each dosage group.*